| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 06/21/2000 | CN1053666C Benzoheterocylic compounds and process for preparing medicated salt thereof |
| 06/21/2000 | CN1053590C Frozen dried heptitis A toxicity-reduced biovaccine and protective agent thereof |
| 06/20/2000 | US6077963 Process to produce a protease inhibitor |
| 06/20/2000 | US6077864 Cyclic sulfone derivatives |
| 06/20/2000 | US6077862 Virus and cancer treatments |
| 06/20/2000 | US6077857 Heterocyclic compounds containing two amide groups which have hemoregulatory activities, can be used to stimulate hematopoiesis and for the treatment of viral, fungal and bacterial infections |
| 06/20/2000 | US6077855 Hemoregulatory compounds |
| 06/20/2000 | US6077832 Antiviral benzimidazole nucleoside analogues and a method for their preparation |
| 06/20/2000 | US6077830 Bismuth salts of antibiotics of the moenomycin group, processes for their preparation, their use and pharmaceuticals comprising such salts |
| 06/20/2000 | US6077706 Helicobacter pylori proteins useful for vaccines and diagnostics |
| 06/20/2000 | US6077690 Dna which encodes a 54 kilodalton protein of specific amino acid sequence; for vaccines, diagnosis of infections, and recombinant production of protein |
| 06/20/2000 | US6077678 Using bacterium or fragment with enhanced antigenic property produced from in vitro culture using bile acids/salts and divalent chelator at specific temperature and gas mixture |
| 06/20/2000 | US6077663 Composition for introducing nucleic acid complexes into higher eucaryotic cells |
| 06/20/2000 | US6077659 Treating erythrocyte/photosensitizer composition with vitamin e, alpha-tocopherol phosphate, alpha-tocopherol succinate, or 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid |
| 06/20/2000 | US6077516 Live vaccine against colibacillosis |
| 06/20/2000 | US6077515 Vaccine comprising whole cells from a purified culture of flagella-less b. burgdorderi having phenotypic characteristics of atcc no. 55131 and a carrier |
| 06/20/2000 | US6077514 Characterized in that the viruses have a codon encoding an amino acid in the f protein chosen from specified amino acids at their amino acid numbers; temperature sensitive rsv phenotype; immunizing |
| 06/20/2000 | US6077511 Antigenic peptide derived from the G protein of RSV for type- and subtype-specific diagnosis of respiratory syncytial virus (RSV) infection |
| 06/20/2000 | US6077510 Borna disease viral sequences, diagnostics and therapeutics for nervous system diseases |
| 06/20/2000 | CA1341029C Peptidase inhibitors |
| 06/15/2000 | WO2000034516A1 Detection of rantes gene promotor polymorphisms |
| 06/15/2000 | WO2000034499A1 Use of an immuno complex for the preparation of a therapeutic composition useful for transfecting a polynucleotide into macropinocyte cells |
| 06/15/2000 | WO2000034498A1 Two-step immunization procedure against chlamydia infection |
| 06/15/2000 | WO2000034496A2 Use of trans-activation and cis-activation to modulate the persistence of expression of a transgene |
| 06/15/2000 | WO2000034495A2 A method of genetically modifying very primitive quiescent human hematopoietic stem cells |
| 06/15/2000 | WO2000034494A1 A recombinant vector expressing multiple costimulatory molecules and uses thereof |
| 06/15/2000 | WO2000034487A1 STREPTOCOCCAL C5a PEPTIDASE VACCINE |
| 06/15/2000 | WO2000034481A2 DRUG TARGETS IN $i(CANDIDA ALBICANS) |
| 06/15/2000 | WO2000034447A2 Human ubiquitin ligase e3 for the modulation of nf-kappa b |
| 06/15/2000 | WO2000034446A1 Inactivation of non-enveloped viruses |
| 06/15/2000 | WO2000034445A2 Live attenuated venezuelan equine encephalitis vaccine |
| 06/15/2000 | WO2000034444A2 Method and composition for preserving viruses |
| 06/15/2000 | WO2000034315A2 Purification of echinocandin cyclopeptide compounds |
| 06/15/2000 | WO2000034308A2 Protein transduction system and methods of use thereof |
| 06/15/2000 | WO2000034303A1 METHODS OF MODULATING TUMOR NECROSIS FACTOR α-INDUCED EXPRESSION OF CELL ADHESION MOLECULES |
| 06/15/2000 | WO2000034298A1 Glyceryl nucleotides, method for the production thereof and their use |
| 06/15/2000 | WO2000034297A1 Carbamate and carbazate ketolide antibiotics |
| 06/15/2000 | WO2000034282A1 1-methylcarbapenem derivatives |
| 06/15/2000 | WO2000034269A1 Thiourea inhibitors of herpes viruses |
| 06/15/2000 | WO2000034268A1 Thiourea inhibitors of herpes viruses |
| 06/15/2000 | WO2000034261A2 Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing a substituted phenylenediamine group |
| 06/15/2000 | WO2000034260A2 Alpha-methylbenzyl-containing thiourea inhibitors of herpes viruses containing a phenylenediamine group |
| 06/15/2000 | WO2000034258A2 Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing phenylenediamine group |
| 06/15/2000 | WO2000034250A1 2,4-dioxo-5-arylidenimino-1,3-pyrimidines |
| 06/15/2000 | WO2000034238A1 Thiourea inhibitors of herpes viruses |
| 06/15/2000 | WO2000034237A2 Acetamide and substituted acetamide-containing thiourea inhibitors of herpes viruses |
| 06/15/2000 | WO2000033893A1 Sterile complex of therapeutic peptide bond to a polysaccharide |
| 06/15/2000 | WO2000033879A1 Method for the treatment of inflammation |
| 06/15/2000 | WO2000033877A1 Anhydrous topical skin preparations |
| 06/15/2000 | WO2000033876A1 Formulation with an improved therapeutic range, containing nucleotide synthesis inhibitors |
| 06/15/2000 | WO2000033875A1 Chemotherapeutic composition and method |
| 06/15/2000 | WO2000033872A2 Method of and compositions for immunization with the pseudomonas v antigen |
| 06/15/2000 | WO2000033844A1 Aryl and heterocyclyl substituted pyrimidine derivatives as anti-coagulants |
| 06/15/2000 | WO2000033833A1 Palladium-substituted bacteriochlorophyll derivatives and use thereof |
| 06/15/2000 | WO2000033828A1 Agent for lowering endothelin levels |
| 06/15/2000 | WO2000033827A1 Bupropion to treat viral diseases |
| 06/15/2000 | WO2000033822A1 Active ingredient matrix in the form of a biologically resorbable porous non-woven made of collagen fibrils, method for the production and use thereof |
| 06/15/2000 | WO2000033814A2 Method for administering agents to the central nervous system |
| 06/15/2000 | WO2000012678A3 Staphylococcus aureus genes and polypeptides |
| 06/15/2000 | WO2000012547A3 Benzodiazepines and benzothiazepines derivatives and hbsag peptides binding to annexins, their compositions and use |
| 06/15/2000 | WO2000012101A3 Use of selenium for treating patients suffering from systemic inflammatory response syndrome (sirs), and composition for implementing said treatment |
| 06/15/2000 | WO2000011023A3 Ring modified cyclic peptide analogs |
| 06/15/2000 | WO2000010600A3 Activation and protection of t-cells (cd4+ and cd8+) using an h¿2? receptor agonist and other t-cell activating agents |
| 06/15/2000 | WO2000009531A3 β-L-2'-DEOXY-NUCLEOSIDES FOR THE TREATMENT OF HEPATITIS B |
| 06/15/2000 | WO2000009107A3 Sulfonamides of n-containing heterocyclic thioesters for vision and memory disorders |
| 06/15/2000 | WO2000006196A3 Multivalent human-bovine rotavirus vaccine |
| 06/15/2000 | WO2000003731A3 Vaccine to prevent and treat chlamydial infections |
| 06/15/2000 | WO1999061452A3 acpS |
| 06/15/2000 | WO1999061056A9 Methods and products for inducing mucosal immunity |
| 06/15/2000 | WO1999061052A9 Oral immunization with papillomavirus virus-like particles |
| 06/15/2000 | WO1999055847A3 Enzymatic nucleic acids molecules which modulate the expressions and/or replication of hepatitis c virus |
| 06/15/2000 | WO1999045016A3 Novel prodrugs for phosphorus-containing compounds |
| 06/15/2000 | WO1999014328A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/15/2000 | WO1999002550A8 Ctl epitopes from ebv |
| 06/15/2000 | DE19857151A1 Powdered, water-soluble chlorhexidine salt, useful e.g. as disinfectant in cosmetics, contains anion from specific sugar acids or their lactones |
| 06/15/2000 | DE19857009A1 Zubereitung mit verbesserter therapeutischer Breite, enthaltend Nukleotidsyntheseinhibitoren Preparation with improved therapeutic index containing nucleotide synthesis |
| 06/15/2000 | DE19856668A1 Wirkstoffmatrix in Form eines biologisch resorbierbaren porösen Vlieses, Verfahren zu ihrer Herstellung und Verwendung Active substance matrix in the form of a biologically resorbable porous nonwoven, methods for their preparation and use |
| 06/15/2000 | CA2678259A1 A recombinant vector expressing multiple costimulatory molecules and uses thereof |
| 06/15/2000 | CA2363310A1 2,4-dioxo-5-arylidenimino-1,3-pyrimidines |
| 06/15/2000 | CA2354374A1 Live attenuated venezuelan equine encephalitis vaccine |
| 06/15/2000 | CA2354266A1 Formulation with an improved therapeutic range, containing nucleotide synthesis inhibitors |
| 06/15/2000 | CA2354150A1 Detection of rantes gene promotor polymorphisms |
| 06/15/2000 | CA2354044A1 Protein transduction system and methods of use thereof |
| 06/15/2000 | CA2354040A1 Aryl and heterocyclyl substituted pyrimidine derivatives as anti-coagulants |
| 06/15/2000 | CA2353930A1 Purification of echinocandin cyclopeptide compounds |
| 06/15/2000 | CA2353525A1 Drug targets in candida albicans |
| 06/15/2000 | CA2351890A1 Method and composition for preserving viruses |
| 06/15/2000 | CA2351690A1 Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing a substituted phenylenediamine group |
| 06/15/2000 | CA2351628A1 Use of trans-activation and cis-activation to modulate the persistence of expression of a transgene |
| 06/15/2000 | CA2351403A1 Thiourea inhibitors of herpes viruses |
| 06/15/2000 | CA2351390A1 Thiourea inhibitors of herpes viruses |
| 06/15/2000 | CA2350996A1 Thiourea inhibitors of herpes viruses |
| 06/15/2000 | CA2350899A1 Acetamide and substituted acetamide-containing thiourea inhibitors of herpes viruses |
| 06/15/2000 | CA2350833A1 Alpha-methylbenzyl-containing thiourea inhibitors of herpes viruses containing a phenylenediamine group |
| 06/15/2000 | CA2350767A1 Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing phenylenediamine group |
| 06/15/2000 | CA2349404A1 Use of an immuno complex for the preparation of a therapeutic composition useful for transfecting a polynucleotide into macropinocyte cells |
| 06/14/2000 | EP1008652A1 Vectors based on recombinant defective viral genomes, and their use in the formulation of vaccines |
| 06/14/2000 | EP1008344A2 The new use of dicaffeoylquinic acid for treating hepatitis b and the diseases related with retrovirus, and the new caffeoylquinic acid derivatives |
| 06/14/2000 | EP1007687A1 Fiv vaccine |
| 06/14/2000 | EP1007686A1 Tuberculosis vaccine |